Status:
COMPLETED
Recovery Guide Intervention for Recurrent Psychiatric Hospitalization
Lead Sponsor:
Yale University
Collaborating Sponsors:
Connecticut State, Department of Mental Health and Addiction Services
Eli Lilly and Company
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether Recovery Guide support services are effective in promoting recovery and social integration among psychiatrically disabled individuals who experience h...
Detailed Description
The paradigm shift in mental health treatment from a deficit-and institution- based framework to a recovery and community integration frame necessitates new models of "case management" practices. The ...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Currently admitted in the Yale-New Haven Psychiatric Hospital (YNHPH)
- A history of two or more prior admissions within the past 18 months
- Proficient in the use of the English language
- A DSM-IV diagnosis of Schizophrenia, Schizoaffective Disorder, Psychotic Disorder NOS, or Major Depressive Disorder with Psychotic Features
Exclusion
- Inability to give signed, written consent
- Primary DSM-IV diagnosis of substance abuse/dependence
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00400166
Start Date
December 1 2006
End Date
May 1 2009
Last Update
June 12 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale-New Haven Psychiatric Hospital
New Haven, Connecticut, United States, 06519